Status:
COMPLETED
The Impact of COVID-19 Pandemic on Hip and Knee Replacement
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Covid19
Hip Arthropathy
Eligibility:
All Genders
18+ years
Brief Summary
During the COVID-19 pandemic, the care of patients undergoing hip or knee replacement for osteoarthritis remains a clinical priority. To date, there is limited empirical knowledge about the impact of ...
Detailed Description
From hospital electronic registry of patients will be possible to screen the patients eligible for the study. From each electronic patients record, health professional researchers will be responsable...
Eligibility Criteria
Inclusion
- Patients undergone hip or knee replacement for osteoarthritis
Exclusion
- Patients undergone hip or knee replacement for fracture, trauma or oncological diseases
Key Trial Info
Start Date :
May 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 10 2022
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04883788
Start Date
May 15 2021
End Date
January 10 2022
Last Update
February 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Ortopedico Rizzoli
Bologna, Italy, 40136